Consenso de inmunizaciones del adulto 2013-2014
Redondo, María Carolyn; Rísquez, alejandro; González Mata, Antonio; Echezuría, Luis; Martín, Amando; Triana, Tibisay; Ferraro, Salvatore.
Bol. venez. infectol
; 25(1): 43-47, ene.- jun. 2014. tab
Artigo em Espanhol | LILACS | ID: lil-718908
Documentos relacionados
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report.
Accidental self-inoculation of a veterinary field worker with Calf Paratyphoid Vaccine.
Parting the Clouds over Typhoid with a New Conjugate Vaccine.
Editorial for "Detection of Neuroinflammation Induced by Typhoid Vaccine Using Quantitative Magnetization Transfer MR: A Randomized Crossover Study".
A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal.
Immunological characterization of chitosan adjuvanted outer membrane proteins of Salmonella enterica serovar Typhi as multi-epitope typhoid vaccine candidate.
Potential of a novel flagellin epitope as a broad-spectrum vaccine candidate against enteric fever.
Syntheses of Salmonella Paratyphiâ A Associated Oligosaccharide Antigens and Development towards Anti-Paratyphoid Fever Vaccines.
Usefulness of the Serial Measurement of Vi Antibodies.
One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine.